相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303
Federico Innocenti et al.
CLINICAL CANCER RESEARCH (2012)
Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics
Ross A. Soo et al.
CURRENT DRUG TARGETS (2012)
A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy
Kazuma Kiyotani et al.
PHARMACOGENETICS AND GENOMICS (2012)
The limits of genome-wide methods for pharmacogenomic testing
Eric R. Gamazon et al.
PHARMACOGENETICS AND GENOMICS (2012)
The 8q24 Gene Desert: An Oasis of Non-Coding Transcriptional Activity
Konrad Huppi et al.
Frontiers in Genetics (2012)
Current status of genome-wide association studies in cancer
Charles C. Chung et al.
HUMAN GENETICS (2011)
Integrating pharmacogenetics into gemcitabine dosing-time for a change?
Joseph Ciccolini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers?
Fredrik Wiklund
GENOME MEDICINE (2010)
Translating the cancer genome into clinically useful tools and strategies
Federico Innocenti et al.
DISEASE MODELS & MECHANISMS (2009)
Clinical pharmacology and pharmacogenetics of gemcitabine
Andrea Wong et al.
DRUG METABOLISM REVIEWS (2009)
The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling
Sari Tuupanen et al.
NATURE GENETICS (2009)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
分享论文
